Ledger.Open graph →
SEC Form D · Amendment · filed February 18, 2015

Reven Pharmaceuticals, Inc

Offering
$7.0M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SARASOTA, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Brian B. Denomme · Sarasota, FLExec · DirectorPeter B. Lange · Sarasota, FLExec · DirectorMichael B. Handley · Sarasota, FLExecMichael A. Volk · Sarasota, FLExecEdward M. Hundert · New York, NYExec · DirectorJeffrey R. Brown · New York, NYExec · DirectorTeresa K. Hassara · New York, NYExecMichael A. Volk · Sarasota, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗